Sharps Stock (NASDAQ:STSS)

Revenue Ownership Financials Chart

Previous Close

$0.38

52W Range

$0.34 - $18.15

50D Avg

$2.23

200D Avg

$4.51

Market Cap

$828.72K

Avg Vol (3M)

$677.96K

Beta

1.19

Div Yield

STSS Company Profile

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Apr 14, 2022

Website

STSS Performance

STSS Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	-	-	-
Operating Income	$-10.13M	$-8.74M	$-4.50M
Net Income	$-9.84M	$779.88K	$-4.83M
EBITDA	$-9.24M	$-13.50M	$-4.47M
Basic EPS	$-0.76	$0.10	$-0.99
Diluted EPS	$-0.76	$0.10	$-0.99

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

Ticker	Company
MBOT	Microbot Medical Inc.
LUCY	Innovative Eyewear, Inc.
NXGL	NEXGEL, Inc.
MHUA	Meihua International Medical Technologies Co., Ltd.
POCI	Precision Optics Corporation, Inc.
AVGR	Avinger, Inc.
KRMD	KORU Medical Systems, Inc.
ZJYL	Jin Medical International Ltd.
GCTK	GlucoTrack, Inc.
UTMD	Utah Medical Products, Inc.